Second Generation Tyrosine Kinase Inhibitors and Their Toxicity in Treatment of Patients in Chronic Phase of Chronic Myeloid Leukemia

Background & Aims. Certain experience in the use of new tyrosine kinase inhibitors (TKIs) in treatment of patients with chronic myeloid leukemia has been obtained over the last years. The article summarizes literature data on toxicity obtained in international clinical trials. The aim of the study i...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	N. S. Lazorko, Elza Galaktionovna Lomaia, E. G. Romanova, E. I. Sbityakova, E. R. Machyulaitene, P. A. Butylin, A. Yu. Zaritskii
Fformat:	Artigo
Iaith:	Russo
Cyhoeddwyd:	Practical Medicine Publishing House 2015-07-01
Cyfres:	Клиническая онкогематология
Pynciau:	chronic myeloid leukemia tyrosine kinase inhibitors toxicity
Mynediad Ar-lein:	https://bloodjournal.ru/index.php/coh/article/view/554
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!